HeartFlow (NasdaqGS:HTFL) FY Conference Summary Company Overview - HeartFlow is a software company utilizing AI for the treatment, diagnosis, and management of coronary artery disease, founded in 2010 with FDA clearance in 2014 [1][2] - The company targets the symptomatic market, estimating a total addressable market (TAM) of $5 billion [2] Key Financial Performance - In 2025, HeartFlow added 340 new accounts, reaching a total of 1,465 accounts, marking the best fiscal year for account additions [2] - Trailing 12 months revenue reached $162 million, reflecting a 41% growth [3] - Strong Q4 performance with no negative surprises, exceeding consensus expectations [3][4] Product and Technology Developments - HeartFlow has developed the world's largest proprietary database of coronary CCTA images, with over 160 million annotated images [3] - The company is expanding its product offerings with plaque analysis, currently live in 489 accounts, with a goal of over 1,000 accounts by the end of 2026 [4][26] - New randomized controlled trials (RCTs) will be initiated in 2026 to expand into the asymptomatic market [4][34] Clinical Evidence and Market Position - HeartFlow has over 600 peer-reviewed publications supporting its clinical evidence [3] - The company aims to create a new standard of care in coronary artery disease, currently having less than 2% market penetration [9][32] - The company’s AI-driven approach is compared to advancements in cancer diagnostics, emphasizing improved accuracy and patient outcomes [8][9] Growth Strategy - HeartFlow's strategy involves starting with the most diseased patients and gradually moving to less urgent cases, including asymptomatic patients [9][34] - The company plans to leverage its existing technology to enter the asymptomatic market, targeting a TAM of $6 billion [34] Market Dynamics and Competition - HeartFlow faces competition from the current standard of care, which is deemed inaccurate [5][32] - The company is focused on educating the market and driving adoption of its plaque analysis technology [40][42] Financial Outlook - HeartFlow aims for profitability within three years post-IPO, targeting 2028 for cash flow break-even [47] - The company expects continued revenue growth driven by its subscription model and expansion into new markets [48] Coverage and Reimbursement - Over 70% of lives are covered for plaque analysis, with a Category I CPT code in place [13][28] - The company is actively working with payers to expand coverage based on clinical data from its DECIDE registry [27][43] Conclusion - HeartFlow is positioned for significant growth with a strong focus on clinical evidence, market education, and expanding its product offerings in the coronary artery disease space [37][48]

GoodRx FY Conference Summary Company Overview - **Company**: GoodRx (NasdaqGS:GDRX) - **Date of Conference**: January 13, 2026 - **Speakers**: CEO Wendy Barnes, CFO Chris McGinnis, and Lisa Gill from JPMorgan Key Industry Dynamics - **Health Benefits Landscape**: Significant changes are occurring, including reductions in ACA subsidies, changes to Medicaid coverage, and an increase in high-deductible plans, which are leading to higher uninsured and underinsured rates [4][5] - **Consumer Behavior**: The trend of underinsurance is pushing more consumers to utilize cash for prescriptions, with approximately 90% of GoodRx users having insurance but still facing high out-of-pocket costs for medications [6] Core Business Insights - **Drug Affordability**: The current administration's focus on drug affordability aligns with GoodRx's mission, although the effectiveness of policy changes remains uncertain [9][10] - **Retail Pharmacy Challenges**: Retail pharmacies are facing closures and margin pressures, prompting GoodRx to partner directly with retailers to enhance their profitability and efficiency [11][12] - **Script Recapture Strategy**: GoodRx aims to recapture scripts from closed pharmacies like Rite Aid, estimating a potential recovery of 20%-40% of those scripts over time [19][21] Subscription Services - **Condition-Based Offerings**: GoodRx launched subscription services for conditions like ED, hair loss, and weight loss in 2025, focusing on branded therapies and competitive pricing [22][25] - **Market Potential**: The company sees significant opportunities in condition subscriptions, particularly in areas where traditional insurance coverage is limited [27] Manufacturer Solutions - **Growth in Manufacturer Solutions**: This segment has grown over 40% year-over-year, driven by manufacturers rethinking their commercial strategies and seeking partnerships with GoodRx to reach consumers effectively [29][30] - **Regulatory Environment**: The favorable regulatory landscape is encouraging manufacturers to engage in direct-to-consumer strategies, enhancing GoodRx's appeal as a partner [32] New Strategic Partnership - **Partnership with Surescripts**: GoodRx announced a partnership with Surescripts to launch "Script Corner," a tool aimed at providing price transparency to patients at the point of prescription [42][43] - **Impact on Patient Care**: The initiative aims to reduce prescription abandonment by providing patients with upfront pricing information, thereby improving adherence to prescribed therapies [55][61] Financial Outlook - **EBITDA Margins**: GoodRx is focused on maintaining cost discipline and expanding EBITDA margins, with potential variability based on strategic investments in marketing and partnerships [38][39] - **Future Guidance**: Specific financial guidance for 2026 will be provided later, but the company is optimistic about its growth trajectory [26][70] Conclusion - **Investor Understanding**: GoodRx aims to clarify its revenue model, emphasizing the integration of manufacturer solutions with its Rx marketplace and the potential for partnerships at the employer level [69][70] - **Commitment to Transparency**: The company is dedicated to enhancing transparency in drug pricing and improving consumer access to affordable medications [58][62]

Veeva Systems FY Conference Summary Company Overview - **Company**: Veeva Systems (NYSE: VEEV) - **Industry**: Life Sciences Software and Consulting - **Market Opportunity**: Approximately $20 billion market with 16% penetration, indicating significant growth potential [6][7] Core Business Model and Vision - **Vision**: To build the industry cloud for life sciences, integrating software, data, and consulting to enhance efficiency across R&D, manufacturing, and commercial sectors [3][6] - **Values**: Emphasis on integrity, customer success, employee success, and speed [4][5] - **Public Benefit Corporation**: Veeva is the first public company to convert to a Public Benefit Corporation, balancing the interests of shareholders, customers, employees, and society [6] Product Portfolio - **Product Suites**: Veeva offers over 10 product suites and more than 50 products, categorized into: - Development Cloud: Clinical, regulatory, and safety management - Quality Cloud: Manufacturing quality assurance - Commercial Cloud: Sales, medical, and marketing solutions - Data Cloud: Data management and analytics [7][9] - **Unique Selling Proposition**: The "suite effect" allows customers to benefit from interconnected products, reducing integration complexities [10][11] Market Dynamics and Trends - **AI Integration**: AI is becoming integral in life sciences, enhancing productivity in drug discovery and clinical trials [17][18] - **Industry Connectivity**: Increased collaboration among stakeholders, leading to faster and more inclusive clinical trials [18] - **Changing Commercial Models**: Shift towards ongoing care and precision medicine as standard practice [18] Financial Performance and Growth Strategy - **Revenue Growth**: Expected revenue of $3.17 billion for the current fiscal year, representing a 15% growth rate [30] - **Long-term Goals**: Targeting $6 billion in revenue by 2030, implying a 13% annual growth rate [27] - **Investment Focus**: Significant investment in product development, with a commitment to maintaining high operating margins (expected 45% non-GAAP) [30][31] Competitive Landscape - **Main Competitors**: Salesforce in CRM and Medidata in clinical areas, with many competitors being niche providers [36][37] - **Market Share**: Veeva holds over 80% market share in biopharma CRM, expecting to maintain over 70% post-migration to Vault CRM [23][24] Capital Allocation and M&A Strategy - **Cash Position**: Over $6.5 billion in cash with no debt, allowing for both M&A and shareholder returns [32][33] - **Share Repurchase Program**: Announced a $2 billion share repurchase over two years to return value to shareholders [33] - **M&A Focus**: Targeting strategic acquisitions to enhance product excellence and expand into cross-industry software [39][40] Customer Engagement and Consulting - **Customer Success**: Veeva's products are designed to be mission-critical, leading to high customer retention and advocacy [14][45] - **Business Consulting**: Growing segment focused on helping customers optimize business processes and implement technology effectively [50][51] Crossix Business Insights - **Digital Marketing Growth**: Crossix continues to show strong growth in digital marketing and measurement, with potential to match CRM size in the future [52][54] - **Market Leadership Potential**: Positioned to gain further market share in a growing digital marketing landscape [53][54] Profitability and Margin Management - **Profitability Strategy**: Focus on sustainable growth without artificial margin targets, allowing for necessary investments in innovation [55][56] - **Operating Leverage**: Anticipated improvements in margins as Salesforce royalties decline and investments in AI and data products yield returns [56] This summary encapsulates the key points from the Veeva Systems FY Conference, highlighting the company's strategic vision, product offerings, market dynamics, financial performance, and future growth opportunities.

Cellectar Biosciences (NasdaqCM:CLRB) 2026 Conference January 13, 2026 04:30 PM ET Company ParticipantsJim Caruso - CEOModeratorYeah. No, the cubs. Cubs. Who are you talking about? Good afternoon. Welcome back to session. My name is Matt Gardner. I'll be your moderator for this afternoon. Our first presenting company in the afternoon session is Cellectar Biosciences from Florham Park, New Jersey. As a Westfield guy, I have great pride introducing you here, Jim. Cellectar is focused on oncology, platform tec ...

Ciena (NYSE:CIEN) FY Conference Summary Company Overview - **Company**: Ciena Corporation - **Industry**: Communications and Networking - **Conference Date**: January 13, 2026 Key Points Financial Performance - Ciena initially guided for 8%-11% growth but achieved a remarkable 19% growth in revenue for the year [7][8] - The company reported $7.8 billion in orders and over $4.8 billion in revenue, ending the year with a backlog exceeding $5 billion [49] Drivers of Growth - The primary driver of growth was attributed to AI, with significant demand from cloud providers, including hyperscalers and new entrants known as NeoScalers [7][8] - The optical systems business saw over 20% growth, with a notable increase in market share, reaching over 30% globally (excluding China) [10][28] Market Dynamics - There is a hyper-competitive environment among cloud providers, leading to unprecedented demand for connectivity infrastructure to support AI training clusters [8][12] - Ciena's cloud customer base grew over 50% year-over-year, with expectations of 70% growth in hyperscale CapEx in 2025 [11] Product Innovations - Ciena has successfully entered the pluggable transceiver market, achieving approximately 15% market share and doubling its business to just under $170 million [19] - The introduction of the 800ZR pluggable transceiver is expected to significantly impact production volume and profitability in 2026 [20] Managed Optical Fiber Networks (MOFN) - MOFN is a growing segment, with over 30 MOFN WANs globally, and it grew about 150% year-over-year in 2025 [30][34] - This segment is expected to approach 50% of Ciena's revenues when combined with direct data center interconnect business [34] New Technologies and Applications - Ciena is developing MultiRail technology to densify existing optical amplifier architecture, which could represent a multi-billion dollar opportunity [66] - The company is also focusing on coherent optics for data centers, anticipating a shift from IMDD to coherent technology as data rates increase [69] Supply Chain and Operational Efficiency - Ciena is facing supply chain challenges, particularly with specialized optical components, but is actively working to address these issues [50][81] - The company has guided for flat operating expenses year-over-year despite significant revenue growth, indicating operational efficiencies and strategic reallocations [90][91] Competitive Landscape - Ciena competes with major players like Nokia, Infinera, and Cisco, with a focus on maintaining a strong position in the optical systems market [96] - The competitive landscape is evolving, with potential consolidation among NeoScalers and ongoing investments in technology and infrastructure [60] Future Outlook - Ciena expects continued growth driven by AI and cloud infrastructure, with a projected CapEx growth rate of 20% among hyperscalers and NeoScalers through the end of the decade [60] - The company aims for mid-40s gross margin as a waypoint in the coming years, despite current headwinds from production ramp-up and input pricing [84] M&A Strategy - Ciena has a history of strategic acquisitions, such as Nubis, to bolster its core business and fill technology gaps [101] Conclusion Ciena is positioned for significant growth driven by AI and cloud demand, with a strong focus on innovation in optical technologies and strategic market positioning. The company is navigating supply chain challenges while maintaining operational efficiency and exploring new market opportunities.

Five9 FY Conference Summary Company Overview - **Company**: Five9 (NasdaqGM:FIVN) - **Industry**: Cloud-based Customer Experience (CX) Software - **Revenue Growth**: From $10 million in 2008 to approximately $1.1-$1.2 billion in 2025, indicating significant growth over the years [5][9] Key Points and Arguments Leadership Transition - **Outgoing CEO**: Mike Burkland will step down but remain as Executive Chair [11] - **Incoming CEO**: Amit Mathradas, noted for his experience in AI and automation, will take over on February 2, 2026 [21][23] Business Model and Growth Drivers - **Core Business**: Five9's traditional CCaaS (Contact Center as a Service) is projected to grow at a 9% CAGR, with 60% of contact centers still using on-premise solutions [24] - **AI Growth**: AI-driven CX is expected to grow at a 34% CAGR, with Five9's AI revenue growing by 41% in the last quarter [24][25] - **Market Opportunity**: The total addressable market (TAM) for contact centers is $24 billion, with only 40% penetration, indicating substantial growth potential [26] Competitive Advantages - **End-to-End Platform**: Five9's integrated platform allows for seamless orchestration of customer interactions, providing a competitive edge over point solutions [34][40] - **Conversational Data**: The platform serves as a system of record for conversational data, enhancing AI capabilities and personalization [40][41] Customer Engagement and Adoption - **AI as a Catalyst**: AI is driving customers to transition from on-premise to cloud solutions, with many enterprises considering AI-first strategies [26][28] - **Large Deals**: Five9 has secured significant contracts with major brands like Wells Fargo, CVS, and FedEx, attributed to its reliable and scalable platform [31][32] Financial Metrics - **Net Revenue Retention (NRR)**: Slight decline from 108% to 107% due to tough comparisons and seasonality, but expected to improve in 2026 with a backlog of new bookings [51][53] - **Profitability Goals**: Targeting a midterm adjusted EBITDA margin of 25%-30% by 2027, driven by operational efficiencies and a growing AI portfolio [55][56] Pricing Strategy - **Consumption-Based Pricing**: Transitioning to interaction-based contracts, allowing flexibility between human and AI interactions [46][47] - **Annual Invoicing**: Moving towards annual invoicing for larger customers to improve cash flow and working capital efficiency [58] Additional Insights - **AI Development**: Five9 employs an engine-agnostic strategy for AI, allowing integration of various models based on customer needs [64][66] - **Implementation Challenges**: New AI product deployments are taking longer due to the complexity of integration compared to previous seat-based models [69] This summary encapsulates the key insights from the Five9 FY Conference, highlighting the company's growth trajectory, leadership changes, competitive advantages, and financial outlook.

Summary of Conference Call Transcript Company Overview - The company discussed is Unisys, focusing on its ECS (Enterprise Computing Solutions) and L&S (Lifecycle Services) segments, particularly the ClearPath product line. Key Points and Arguments Financial Performance - The ECS segment is expected to maintain a margin of around 70%, with annual revenue projected at approximately $400 million, indicating strong cash flow and profitability [2][19]. - The Digital Workplace Solutions (DWS) segment includes five key solutions, with a consistent margin profile expected in the low to mid-20% range [8][10]. - The total addressable market (TAM) for CANI (Cloud Applications and Infrastructure) is estimated at $600 billion, with a compound annual growth rate (CAGR) of 10%-12%, while DWS has a TAM of $150 billion with a CAGR of 5%-8% [10]. AI Integration - AI is viewed as a benefit to the business, enhancing consumption and operational efficiency, particularly through the ClearPath Forward operating system [3][12]. - Real-world applications of AI include the Generative and Agentic AI in the service desk solution, which improves customer service efficiency and knowledge management [12][14]. Competitive Landscape - Unisys claims minimal competition in the ClearPath Forward platform, with IBM's Z Series being the closest alternative, but they do not typically lose clients to competitors [5][17]. - The competitive environment is described as historically competitive, with increased pricing pressure due to AI's impact on revenue [17]. Margin Improvement Strategies - The company has improved its margin profile by approximately 600 basis points over the last few years and sees further opportunities for enhancement through offshore delivery and AI adoption [18][19]. - The current revenue mix is 80% recurring, which stabilizes the business but may limit margin potential compared to a more consultative approach [19]. Growth Outlook - Unisys anticipates a normalized growth rate of 3%-5% CAGR for the overall company, with some segments expected to grow faster [20]. Pension Management - The company has reduced pension liabilities by $2.5 billion over five years and aims for full defeasance of the pension plan within three to five years [22][25]. - Recent transactions have improved cash flow and mitigated pension contribution volatility, which is expected to enhance net leverage [23][24]. Capital Allocation - Future capital allocation priorities include business growth, potential equity buybacks, and debt reduction once pension issues are resolved [26]. Market Perception - The company believes that the market undervalues its ECS and L&S segments, which could be worth more than the current market cap based on discounted cash flows [28][29]. - There is a need for improved communication with investors to clarify the company's value proposition and operational improvements [29]. Additional Important Insights - The company emphasizes the importance of maintaining pricing discipline amidst competitive pressures and the need for transparency in communicating its growth story to investors [17][29].

Summary of NANO Nuclear Energy FY Conference Call Company Overview - **Company**: NANO Nuclear Energy (NasdaqCM:NNE) - **Focus**: Development of next-generation micro-reactors, nuclear fuel fabrication, and transportation technology aimed at providing smaller, simpler, and safer clean energy solutions [1] Key Areas of Focus - **Micro-Reactors**: The company is concentrating on micro-reactors, particularly the Kronos MMR, which has a capacity of approximately 15 megawatts electric [2] - **Market Applications**: Potential applications include data centers, industrial power needs, military bases, remote communities, and various process heat applications like desalination [2] Industry Dynamics - **Nuclear Renaissance**: The company is benefiting from a global nuclear renaissance driven by strong demand for clean, reliable base load energy, climate mandates, and bipartisan government support [3][4] - **Corporate Interest**: Major tech companies (Microsoft, Amazon, Google, etc.) are expanding their nuclear capabilities, indicating a growing reliance on nuclear energy for data centers [4] Value Proposition of Nuclear Energy - **Base Load Power**: Nuclear energy is recognized as the ideal source for base load power due to its reliability, zero emissions, and high capacity factor [5] - **Growth Commitment**: Countries and major companies are committing to significantly increase nuclear capacity by 2050, with the U.S. aiming to quadruple its capacity [5] Micro-Reactor Advantages - **Cost and Safety**: Micro-reactors are designed to address challenges faced by traditional reactors, such as long approval times and high construction costs, while enhancing safety through factory fabrication and modular assembly [8][9] - **Economies of Scale**: The design allows for cost-effective scaling and reduced initial capital expenditures, which is attractive to potential customers [9] Kronos MMR Specifics - **Design and Technology**: The Kronos MMR utilizes TRISO fuel and is nearing the formal licensing process in the U.S. and Canada, with significant prior investment and historical deployment data supporting its design [12][11] - **Licensing Timeline**: The company plans to submit a construction permit application in early 2026, aiming for operational status by 2029 or 2030 [21][36] Strategic Partnerships and Projects - **University of Illinois**: A prototype project is planned at the University of Illinois, with strong support from the university and state incentives [22][21] - **Chalk River Project**: A potential second prototype in Ontario, Canada, is being explored, which could benefit from the licensing progress made in the U.S. [23] Fuel Supply Chain and Vertical Integration - **Self-Sufficient Supply Chain**: The company is focused on vertical integration to ensure a self-sufficient nuclear fuel supply chain, including partnerships for enrichment and fuel transportation [25][26] - **LIS Technologies**: Collaboration with LIS Technologies aims to address enrichment bottlenecks, leveraging advanced laser-based enrichment technology [27][29] Financial Outlook and Valuation - **Market Valuation**: NANO Nuclear Energy's current valuation is approximately $1.7 billion, significantly lower than peers valued at $6 billion to $16 billion, indicating a potential valuation disconnect [32] Conclusion - **Growth Potential**: The company is optimistic about its growth trajectory, with a strong pipeline of commercial opportunities and plans for significant progress in licensing and project development in 2026 [32][19]

Summary of Ambarella's Conference Call Company Overview - **Company**: Ambarella - **Industry**: Semiconductor, specifically focusing on edge AI applications - **Core Products**: AI semiconductors used in video security, autonomous driving, telematics, and other robotic applications - **Revenue Source**: Approximately 80% of revenue comes from edge AI applications [2][5] Transformation and Product Development - Ambarella has transformed from a video processor company for consumer applications to an AI SoC provider for intelligent edge applications over the past decade [5][6] - The company has developed three generations of AI accelerators, with the second generation (CV2 family) representing 80% of total revenue [7][10] - The third generation architecture incorporates transformer-based models, which are expected to open larger market opportunities compared to CNN-based models [8][10] Market Opportunities and Growth - The company anticipates significant growth in transformer-based revenue, which is expected to coexist with CNN-based revenue [11][12] - The average selling price (ASP) for the CV2 family ranges from $15 to $75, while the third generation (CV3, CV7, N1) has an ASP of $20 to $400, indicating potential for significant revenue growth [13][14] - New applications for transformer technology include autonomous driving and advanced robotics, with examples provided from CES demonstrations [17][19] Business Segments and Performance - Ambarella's enterprise security camera market remains strong, but telematics and portable video markets have shown unexpected growth [34][35] - The company expects continued growth in enterprise security and telematics, with ASP and unit growth driving performance [36] - The IoT business is diversifying, with security now accounting for less than 50% of the IoT revenue, down from previous years [50][52] Edge Infrastructure and AI Applications - The N1 AI box is designed to aggregate edge endpoints, enhancing existing security cameras with Gen AI capabilities [55][59] - The edge infrastructure business is expected to have higher ASPs but similar gross margins compared to the overall corporate average of 59%-62% [59][60] Automotive Market Insights - The automotive market is currently facing delays in Level 2+ design wins, but Ambarella continues to focus on securing partnerships with OEMs [62][63] - The company is leveraging its investments in autonomous driving technology for broader robotic applications, including drones [63][64] Software and Licensing Opportunities - Ambarella has developed two large models for end-to-end AI applications and is open to licensing these models to OEMs [65][66] - The company is focusing on securing design wins for both hardware and software revenue, with licensing as an additional revenue stream [66] Future Outlook - Ambarella is optimistic about the growth potential in both existing and new markets, with plans to provide official guidance for fiscal 2027 in February [36][37] - The company is exploring custom ASIC projects with large customers, which could enhance revenue and market presence [41][42] Key Takeaways from CES - New product announcements, including the CV7 chip, which offers improved AI performance and lower power consumption [37][38] - Introduction of a new go-to-market strategy to engage partners for addressing segmented markets [38][39] - Engagement in custom chip design with large customers, focusing on leveraging Ambarella's IP [41][42] This summary encapsulates the key points discussed during the conference call, highlighting Ambarella's strategic direction, market opportunities, and future growth potential.

Summary of FormFactor's Conference Call Company Overview - **Company**: FormFactor - **Industry**: Semiconductor testing equipment - **Recent Revenue**: Trailing 12-month revenues approximately $750 million, with guidance for Q4 indicating an annual run rate closer to $800 million [6][11] Business Segments - **Probe Cards**: The largest segment, serving as connectors between test equipment and customer wafers, crucial for testing chips before assembly. Increased demand driven by advanced packaging technologies like high bandwidth memory (HBM) [6][7] - **Engineering Systems**: Focused on co-packaged optics (CPO), aiding customers in R&D and addressing power consumption issues in data centers [8][9] Market Position and Strategy - **Key Customers**: Strong relationships with major DRAM manufacturers, particularly SK Hynix, which represents 10% of FormFactor's revenue [19] - **Competitive Advantage**: Unique capabilities in high-speed and RF testing, particularly for HBM applications, allowing for high parallelism and productivity in testing [20][21] - **Future Technology**: Transitioning to hybrid bonding in HBM may require new probing technologies, which FormFactor is prepared for due to its experience with copper probing [28] Growth Drivers - **HBM and DRAM**: Anticipated growth in DRAM, particularly DDR5, with expectations to set records in probe card sales. Current market dynamics suggest a shortage in supply due to clean room constraints [55][56] - **GPU and ASIC Testing**: Increased focus on GPU testing due to long test times and high transistor counts, with FormFactor adapting its technology to meet these demands [31][36] Operational Changes - **Factory Realignment**: Recent consolidation of manufacturing sites in California and the establishment of a new site in Farmers Branch, Texas, aimed at increasing efficiency and capacity [12][14][70] - **Gross Margin Improvement**: Targeting a gross margin of 47% by 2026, with recent improvements from 38.5% to a projected 42% in Q4, driven by operational efficiencies and cost structure optimization [11][66][70] Challenges and Considerations - **Market Dynamics**: The company faces challenges from tariff impacts, which are estimated to be a 200 basis points headwind to gross margins [70] - **NAND Business**: Limited focus on NAND due to its commodity nature and lack of differentiation opportunities [54] Future Outlook - **CPO and Optical Probing**: Continued investment in CPO technologies, with expectations for significant growth in AI applications. Integration of electrical and optical probing technologies is anticipated [42][43] - **Capacity Expansion**: The new Texas facility is expected to ramp up production by the end of 2026, aligning with anticipated market demand [70][71]